LIVE MARKET TRACKER :   BSE SENSEX   32389.96      |    NSE NIFTY 10146.55    
GLOBAL MARKETS :  NASDAQ 6585.9185   -0.5782%    |    FSI London 7523.30   -0.26%    |    NIKKEI Japan 21448.52   +0.40%
  USD GBP EUR CAD AUD INR
USD - 0.7572 0.8440 1.2465 1.2693 65.0490
GBP 1.3206 - 1.1142 1.6461 1.6759 85.7903
EUR 1.1854 0.8976 - 1.4776 1.5043 77.0144
CAD 0.8024 0.6079 0.6769 - 1.0187 52.1410
AUD 0.7880 0.5968 0.6649 0.9822 - 51.1810
INR 0.0154 0.0117 0.0130 0.0192 0.0196 -
Indian-Commodity  :  Corporate  :  Panacea Biotec planning to raise Rs 250 crore

Panacea Biotec planning to raise Rs 250 crore (26-Sep-2017)

Panacea Biotec is planning to raise Rs 250 crore by way of issue of equity shares and/or other securities. In this regards, the company is conducting Postal Ballot for obtaining approval of members for passing special resolution.

The Notice is being dispatched to the shareholders of the Company whose names appear in the Register of Members of the Company as on the cut-off date i.e. September 15, 2017 and the same is being sent to the members of the company through e-mail / post.

The company has also provided remote e-voting facility to the members to vote electronically through e-voting platform provided by NSDL.

Panacea Biotec is a leading biotechnology company with established research, manufacturing and marketing capabilities. It is one of the largest vaccine producers and leading Biotechnology Companies in India.


Top News Today
Suven Life Sciences secures product patent in Singapore
(18-Oct-2017)

Suven Life Sciences secures product patent in SingaporeSuven Life Sciences has secured one product patent from Singapore corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents......click on news to read complete article.

Jubilant Life Sciences issues commercial papers worth Rs 50 crore
(18-Oct-2017)

Jubilant Life Sciences issues commercial papers worth Rs 50 croreJubilant Life Sciences has issued Commercial Papers (CPs) aggregating to Rs 50 crore on October 17, 2017. The company has issued two commercial papers of Rs 25 crore each providing an interest rate of......click on news to read complete article.

Peninsula Land receives Rs 200 crore from Godrej Skyline for Pune land
(18-Oct-2017)

Peninsula Land receives Rs 200 crore from Godrej Skyline for Pune landPeninsula Land has received Rs 200 crore out of the total consideration of Rs 226 crore from Godrej Skyline Developers for sale of property situated at Village Mamurdi, Taluka Haveli, District - Pune,......click on news to read complete article.

International Stock News
Asian markets trade mostly lower in early deals on Wednesday
(18-Oct-2017)

Asian markets trade mostly lower in early deals on WednesdayMost of the Asian equity benchmarks are trading lower in the early deals on Wednesday with investors trading cautiously as China's President Xi Jinping spoke at the beginning of the Communist Party's 19th......click on news to read complete article.

US markets closed mostly higher on round of positive earnings report
(18-Oct-2017)

US markets closed mostly higher on round of positive earnings reportThe US markets closed mostly higher on Tuesday, with both the Dow and the S&P 500 finishing at records as a round of positive earnings report from major companies boosted positive sentiment and......click on news to read complete article.

Asian markets trade mostly higher in early deals on Tuesday
(17-Oct-2017)

Asian markets trade mostly higher in early deals on TuesdayMost of the Asian equity benchmarks are trading in green in the early deals on Tuesday, with the fresh record highs on Wall Street and firm commodity prices boosting investors' sentiments. Comments by......click on news to read complete article.

 

     
  
Recent Corporate News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.